Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.669, 2013-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tocilizumab ± methotrexate beneficial for RA
Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. :
Etanercept dominates therapy options for RA in Mexico
Inpharma, Vol. 1, Iss. 1503, 2005-01 ,pp. :
Etanercept dominates therapy options for RA in Mexico
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 485, 2005-01 ,pp. :
Adalimumab adds to methotrexate efficacy in RA
Inpharma, Vol. 1, Iss. 1645, 2008-01 ,pp. :
Tocilizumab adds to benefit with methotrexate in refractory RA
Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. :